Please login to the form below

Not currently logged in
Email:
Password:

personalised medicines

This page shows the latest personalised medicines news and features for those working in and with pharma, biotech and healthcare.

Immuno-oncology, personalised medicine continues to drive pharma sector

Immuno-oncology, personalised medicine continues to drive pharma sector

Coming in after I-O and personalised medicines as the top most impactful trends was the growing role of  real-world evidence and a rise in the use of  electronic health ... Personalised medicines have been identified as key treatments by the UK’s

Latest news

More from news
Approximately 13 fully matching, plus 57 partially matching documents found.

Latest Intelligence

  • From if to how: when imagination and regulation work together From if to how: when imagination and regulation work together

    This is an equation in which continued investment in research, development of novel medicines and increasingly personalised solutions are balanced against maintaining sustainability of healthcare systems during a global economic downturn.

  • The dawn of a new era in medical education The dawn of a new era in medical education

    By Annlouise Pendse. We are living in a pivotal moment in medical history. The first wave of personalised medicines is now available and is changing the way diseases are identified and ... delivering often complex personalised medicine.

  • The first, my last, my everything The first, my last, my everything

    This growing empowerment arguably has its biggest impact in the arena of high-value medicines. ... We need a better understanding of patients. We’re heading rapidly towards personalised medicines, yet we’re still not personalising the value that we

  • Genomics integration: can the NHS rise to the challenge? Genomics integration: can the NHS rise to the challenge?

    We can then make sure personalised medicine treatment is targeted to the individual so they get the best treatment at the right point in time. ... Last year, NHS England announced that it will focus on earlier diagnosis and more personalised medicines

  • “Brexit has been a catalyst for UK clinical research... it’s turbocharged change” “Brexit has been a catalyst for UK clinical research... it’s turbocharged change”

    National Institute for Health Research (NIHR) and the UK’s medicines regulator the MHRA. ... The partnership will aim to enable faster and more efficient drug research, generate more robust evidence to support treatment value, and ultimately provide

More from intelligence
Approximately 4 fully matching, plus 18 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics